Xu Y - Search Results

1

Xu Y, Yuan Y, Fu DQ, Fu Y, Zhou S, Yang WT, Wang XY, Li GX, Dong J, Du F, Huang X, Wang QW, Tang Z. Xu Y, et al. Bioorg Med Chem. 2023 May 15;86:117299. doi: 10.1016/j.bmc.2023.117299. Epub 2023 Apr 27. Bioorg Med Chem. 2023. PMID: 37137271

2

Clinical characteristics, prognosis, and prognostic factors of patients with second primary triple-negative breast cancer: a study based on Surveillance, Epidemiology, and End Results database.

Ding L, Xu Y, Li C, Chen X. Ding L, et al. Among authors: xu y. Eur J Cancer Prev. 2024 Nov 21. doi: 10.1097/CEJ.0000000000000929. Online ahead of print. Eur J Cancer Prev. 2024. PMID: 39602200

3

Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.

Lin J, Zhou J, Xu Y. Lin J, et al. Among authors: xu y. Brain. 2023 Aug 1;146(8):3364-3372. doi: 10.1093/brain/awad070. Brain. 2023. PMID: 36864689 Free PMC article.

4

Gold-Catalyzed Precise Bromination of Polystyrene.

Dou B, Xu Y, Wang J. Dou B, et al. Among authors: xu y. J Am Chem Soc. 2023 May 10;145(18):10422-10430. doi: 10.1021/jacs.3c03069. Epub 2023 May 1. J Am Chem Soc. 2023. PMID: 37126502

5

Immune checkpoint inhibitors for the treatment of non-small cell lung cancer brain metastases.

Wei Y, Xu Y, Wang M. Wei Y, et al. Among authors: xu y. Chin Med J (Engl). 2023 Jul 5;136(13):1523-1531. doi: 10.1097/CM9.0000000000002163. Chin Med J (Engl). 2023. PMID: 37106555 Free PMC article. Review.

6

Efficacy of prolonged intravenous lidocaine infusion for postoperative movement-evoked pain following hepatectomy: a double-blinded, randomised, placebo-controlled trial.

Xu Y, Ye M, Liu F, Hong Y, Kang Y, Li Y, Li H, Xiao X, Yu F, Zhou M, Zhou L, Jiang C. Xu Y, et al. Br J Anaesth. 2023 Jul;131(1):113-121. doi: 10.1016/j.bja.2023.03.026. Epub 2023 May 16. Br J Anaesth. 2023. PMID: 37202261 Free article. Clinical Trial.

7

Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness: a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial.

Tian X, Xu Y, Wang L, Dong C, Yan X, Fan J, Xie H, Zhang H, Wang J, Liu Y, Wang Y, Pan S, Wu A, Liu X, Yao C, Wang M. Tian X, et al. Among authors: xu y. Trials. 2024 Jan 22;25(1):77. doi: 10.1186/s13063-024-07914-3. Trials. 2024. PMID: 38254211 Free PMC article.

8

Characterization of renal injury in non-squamous non-small cell lung cancer patients treated with pemetrexed: A single-center retrospective study.

Wu Y, Miao K, Chen M, Xu Y, Zhong W, Wang H, Si X, Zhang X, Zhang L, Zhao J, Wang M. Wu Y, et al. Among authors: xu y. Thorac Cancer. 2024 Dec;15(35):2474-2485. doi: 10.1111/1759-7714.15470. Epub 2024 Oct 29. Thorac Cancer. 2024. PMID: 39468864 Free PMC article.

9

Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers.

Liang H, Xu Y, Zhao J, Chen M, Wang M. Liang H, et al. Among authors: xu y. Cancer Gene Ther. 2024 May;31(5):652-666. doi: 10.1038/s41417-024-00761-z. Epub 2024 Mar 18. Cancer Gene Ther. 2024. PMID: 38499647 Free PMC article. Review.

10

Case report: Checkpoint inhibitor pneumonitis with positive anti-melanoma differentiation-associated gene 5 antibodies in a patient with lung cancer.

Pan S, Xie H, Wang L, Wang Y, Zou M, Xu Y, Tian X, Fan J, Wang J. Pan S, et al. Among authors: xu y. Front Immunol. 2024 Jan 12;14:1309531. doi: 10.3389/fimmu.2023.1309531. eCollection 2023. Front Immunol. 2024. PMID: 38283343 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,132 results

Search Page

Filters